Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
Rev. argent. endocrinol. metab ; 55(2): 11-20, jun. 2018. graf
Article in Spanish | LILACS | ID: biblio-1041732

ABSTRACT

RESUMEN Los pacientes con adenomas hipofisarios constituyen una población heterogénea y requieren un enfoque individualizado. El objetivo de nuestro trabajo fue analizar nuestra población con adenomas hipofisarios no funcionantes (ACNF) y evaluar factores pronóstico de crecimiento (como el Ki-67) que ayuden en la toma de decisiones. Se realizó un análisis retrospectivo de 202 pacientes, incluyendo evaluación basal, enfoque terapéutico y evolución tumoral en 2 grupos: pacientes con conducta expectante (n = 69) y pacientes con cirugía (n = 133). La serie tuvo 55% de pacientes mujeres y la edad media al diagnóstico fue de 49 años. Los motivos de consulta más frecuentes fueron incidentaloma hipofisario y alteraciones visuales. Radiológicamente, 83% fueron macroadenomas, 77% invasivos y 55% mostraron compromiso visual. Entre los adenomas invasores, el 53% tenían disfunción hipofisaria, siendo el hipogonadismo el hallazgo más frecuente. El tratamiento inicial fue la cirugía en el 65,8% realizándose por vía transnasal en el 79% de los casos. Las complicaciones más frecuentes fueron diabetes insípida transitoria e hiponatremia, con mayor incidencia de diabetes insípida permanente en la cirugía transcraneal. La inmunohistoquímica mostró gonatropinomas en el 43,4% de los casos y fue negativa en el 37,7%. Doce adenomas tuvieron índice de proliferación Ki-67 ≥3%. Luego de la cirugía 56,8% de los pacientes mejoraron el campo visual, 22,6% recuperó alguna función endocrina y 18,8% agregó un nuevo déficit. En pacientes no operados, se observó crecimiento tumoral en 5,6% de los adenomas Hardy 1-2 y en el 21% de los Hardy 3-4. Entre los adenomas operados, aquellos sin resto tumoral postoperatorio no presentaron recurrencia. De los tumores con remanente postoperatorio (78,6%) no irradiados, el 41,5% mostró recrecimiento lesional al seguimiento. Este porcentaje se eleva a 66,6% en aquellos con Ki-67 ≥3% y disminuye a 12% en los que recibieron radioterapia.


ABSTRACT Patients with pituitary adenomas are a heterogeneous population and require an individualized approach. The aim of our study was to analyze our population of patients with nonfunctioning pituitary adenomas (NFA) and to evaluate prognostic growth factors (such as Ki-67) that help in decision making. A retrospective analysis of 202 patients, including baseline assessment, therapeutic approach and tumor evolution was performed in 2 groups: expectant management (n = 69) and surgery (n = 133). The mean age at diagnosis was 49 years, 55% women. The most frequent reasons for consultation were pituitary incidentaloma and visual impairment. Eighty three percent were macroadenomas, 77% invasive, and 55% with visual impairment. Among the invasive adenomas, 53% had pituitary dysfunction, with hypogonadism being the most frequent finding. The initial treatment was surgery in 65.8%, 79% of them through transnasal approach. The most frequent complications were transient diabetes insipidus and hyponatremia, with a higher incidence of permanent diabetes insipidus in transcranial surgery. The immunohistochemistry showed: 43.4% gonadotropinomas, 37.7% negative. Twelve adenomas had proliferation index Ki-67 ≥3%. After surgery, 56.8% improved the visual fields, 22.6% recovered some endocrine function and 18.8% added a new deficit. In non-operated patients, tumor growth was observed in 5.6% of the Hardy 1-2 adenomas and 21% of the Hardy 3-4 adenomas. Among the operated adenomas, those without postoperative tumor residue did not present recurrence. In tumors with non-irradiated postoperative remnant (78.6%), 41.5% increased. This percentage rises to 66.6% in those with Ki-67 ≥3%, and decreases to 12% in those who received radiotherapy.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Pituitary Neoplasms/complications , Pituitary Neoplasms/physiopathology , Adenoma/complications , Pituitary Neoplasms/surgery , Prognosis , Adenoma/radiotherapy , Decision Making , Cell Proliferation
2.
Rev. otorrinolaringol. cir. cabeza cuello ; 77(1): 27-34, mar. 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-845643

ABSTRACT

Introducción: La cirugía endoscópica transesfenoidal en la exéresis de patología hipofisaria ha sido ratificada dentro de la mejores opciones para conseguir abordajes exitosos. Para cerrar la brecha ósea, se puede utilizar el colgajo nasoseptal, el cual lograría un cierre adecuado y seguro, evitando complicaciones como persistencia de fístulas de líquido cefalorraquídeo. Dentro de los probables efectos secundarios de este colgajo se señala la presencia de anosmia o hiposmia. Objetivo: Nuestro objetivo es mostrar los resultados obtenidos empleando la técnica del colgajo nasoseptal y la evaluación del olfato posoperatorio. Material y método: Incluimos 14 pacientes con diagnóstico de adenoma hipofisiario intervenidos en nuestro servicio entre diciembre 2014 a diciembre 2015. Se evaluaron diversos parámetros entre otros, olfatometría pre y posoperatorias. A todos se les realizó la técnica endoscópica transesfenoidal. Efectuando la disección del colgajo con la técnica tipo Hadad. La exéresis tumoral fue realizada por neurocirujano, se cubrió la osteotomía con este colgajo. Resultados: De los 14 pacientes, 13 llegaron al estado olfativo preoperatorio. 1 paciente se mantuvo hipósmico mantenidamente. En nuestro estudio, no hemos encontrado deterioro significativo en la calidad del sentido del olfato. Así como tampoco observamos otras complicaciones. Conclusiones: Esta experiencia aún inicial, estimamos que podría ya esbozar una tendencia de mantención de la función olfativa en este tipo de cirugía.


Introduction: Transsphenoidal endoscopic surgery resection of pituitary pathology has been ratified within the best options for successful approaches. To close the gap bone, you can use the nasoseptal flap, which achieved an adequate and secure closure, preventing complications such as persistent cerebrospinal fluid leaks. Among possible side effects of this flap anosmia-hyposmia noted. Aim: Our goal is to show the results obtained using the technique of nasoseptal flap and postoperative evaluation of smell. Material and method: We included 14 patients with a diagnosis of pituitary adenoma surgery in our department between December 2014 to December 2015. Various parameters were evaluated pre and post operative, specially olfactory function. All underwent transsphenoidal endoscopic technique. Performing dissection flap with the technical type Hadad. The tumor resection was performed by neurosurgeon, osteotomy covered with this flap. Results: Of the 14 patients, 13 reached the olfactory preoperative state. 1 patient remained with hyposmia. In our study, we found no significant deterioration in the quality of the sense of smell. Not other complications were found. Conclusions: This is an initial experience, and we estimate that could outline a trend of maintaining olfactory function in this surgery approach.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Adenoma/surgery , Endoscopy/methods , Pituitary Neoplasms/surgery , Sphenoid Sinus/surgery , Adenoma/physiopathology , Epidemiology, Descriptive , Nasal Septum/blood supply , Pituitary Neoplasms/physiopathology , Smell/physiology , Surgical Flaps , Treatment Outcome
3.
Arch. argent. pediatr ; 115(1): 43-49, feb. 2017. tab
Article in English, Spanish | LILACS, BINACIS | ID: biblio-838318

ABSTRACT

Introducción. los craneofaringiomas son malformaciones histológicamente benignas entre el hipotálamo y la hipófisis que pueden afectar la secreción hormonal clave en la regulación endócrina y modulación de la saciedad. Si bien se trata de una enfermedad relativamente benigna, la combinación de obesidad grave de origen hipotalámico y las comorbilidades asociadas a ella disminuyen la calidad de vida. Objetivo. Evaluar el estado nutricional de pacientes operados de craneofaringioma infantil. Población y métodos. Pacientes menores de 21 años al momento del estudio que requirieron cirugía por craneofaringioma en el Hospital de Pediatría Garrahan y que firmaron el consentimiento informado. Se realizó la evaluación antropométrica, composición corporal con impedanciometría, gasto energético con calorimetría indirecta e ingesta energética. Se determinó la resistencia a la insulina y la dislipidemia. Resultados. Se incluyeron 39 pacientes; 41%, normopeso y 59%, obesos. El 68% de los pacientes presentó distribución grasa central; 40%, resistencia a la insulina; y 32%, dislipidemia. No se encontraron diferencias significativas en la presencia de resistencia a la insulina, dislipidemia, gasto energético en reposo ni en la ingesta entre obesos vs. normopeso. El 77% de los pacientes obesos presentó bajo gasto energético independiente del porcentaje de masa magra (62 ± 2,7% vs. 61,2 ± 1,8% de gasto energético en reposo normal vs. bajo; p 0,8). Conclusiones. El 59% de la población estudiada presentó obesidad. No se encontraron diferencias significativas en complicaciones metabólicas entre pacientes obesos y normopeso. Se observó menor gasto energético independiente del porcentaje de masa magra y similar ingesta energética.


Introduction. Craniopharyngiomas are histologically benign malformations located between the pituitary and hypothalamus that may affect key hormone secretion for endocrine regulation and satiety modulation. Although this is a relatively benign disease, the combination of severe hypothalamic obesity and associated comorbidities results in a reduced quality of life. Objective. To assess the nutritional status of patients after craniopharyngioma surgery. population and Methods. Patients younger than 21 years old at the time of the study who required craniopharyngioma surgery at Hospital de Pediatria Garrahan and who signed an informed consent. Anthropometric characteristics, body composition by impedance analysis, energy expenditure by indirect calorimetry and energy intake were assessed. Insulin resistance and dyslipemia were estimated. Results. A total of 39 patients were included; 41% had a normal weight and 59% were obese. Overall, 68% of patients had a central fat distribution; 40% had insulin resistance; and 32%, dyslipemia. No significant differences were observed in terms of insulin resistance, dyslipemia, energy expenditure at rest, or energy intake between normal weight and obese patients. Among obese patients, 77% had a low energy expenditure, regardless of their percentage of lean body mass (62 ± 2.7% versus 61.2 ± 1.8% of normal versus low energy expenditure at rest; p = 0.8). Conclusions. A total of 59% of the studied population was obese. No significant differences were observedinterms ofmetabolic complications between normal weight and obese patients. A lower energy expenditure was observed, regardless of the lean body mass percentage and a similar energy intake.


Subject(s)
Humans , Child, Preschool , Child , Adolescent , Young Adult , Pituitary Neoplasms/surgery , Pituitary Neoplasms/physiopathology , Nutritional Status , Craniopharyngioma/surgery , Craniopharyngioma/physiopathology , Nutrition Assessment , Prospective Studies
4.
Arq. neuropsiquiatr ; 68(3): 350-354, June 2010. tab
Article in English | LILACS | ID: lil-550264

ABSTRACT

Intrasellar pressure (ISP) measurement technique has recently opened a new line of research in neuroendocrinology. The absolute and mean ISP values were investigated in 25 patients consecutively operated at the Brasilia University Hospital (DF). These data were correlated with serum prolactin levels, number of visual quadrant affected, tumor size, quality of life (measured through the SF-36 scale) and graded headache (measured through the HIT-6 scale). No correlation was observed. The p values were 0.887; 0.137; 0.892; 0.812 and 0.884; respectively. The HIT-6 values were inversely and moderately correlated with total RAND SF-36 and its mental and physical dimensions.


A técnica da medida da pressão intra-selar (PIS) abriu, recentemente, uma nova linha de pesquisa em neuroendocrinologia. O objetivo deste estudo foi aferir os valores absolutos da PIS e calcular a pressão intra-selar média (PIM) em uma população de 25 pacientes operados consecutivamente no Hospital Universitário de Brasília (DF). Não se observou correlação significativa entre a PIM e o número de quadrantes visuais comprometidos (p=0,137), área do tumor (p=0,892), nível de qualidade de vida mensurado pela escala SF-36 (p=0,812) e a presença e a intensidade da cefaléia mensurada pela escala HIT-6 (p=0,884). Contudo, o HIT-6 correlacionou-se de forma inversa e intensidade moderada com os valores de HIT-6 e suas dimensões mental e física.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Adenoma/complications , Headache/etiology , Pituitary Neoplasms/complications , Quality of Life/psychology , Visual Fields/physiology , Adenoma/physiopathology , Adenoma/surgery , Headache/psychology , Intracranial Pressure/physiology , Pressure , Pituitary Neoplasms/physiopathology , Pituitary Neoplasms/surgery , Severity of Illness Index , Young Adult
5.
Arq. bras. endocrinol. metab ; 51(9): 1522-1527, dez. 2007. tab
Article in Portuguese | LILACS | ID: lil-471774

ABSTRACT

A hiperprolactinemia tumoral e conseqüente hipogonadismo têm sido associados à osteoporose. Avaliamos a densidade mineral óssea (DMO) por absortometria com dupla fonte de RX em 24 mulheres entre 18 e 49 anos, com prolactinoma (15 macro e 9 micro). Utilizamos teste t de Student não pareado ou Mann-Whitney para comparar subgrupos, e teste de Spearman para correlações. O maior acometimento foi de coluna lombar, onde 20,83 por cento das pacientes tinham Z-escore < -2 DP. Não detectamos diferenças densitométricas entre macro e microprolactinomas, nem entre pacientes com prolactina normal versus as hiperprolactinêmicas. A DMO e o Z-escore na coluna foram maiores nas pacientes com > 8 ciclos menstruais no ano anterior à densitometria versus as oligoamenorréicas (p = 0,030). O número de ciclos/ano correlacionou-se com a DMO na coluna (r = 0,515, p = 0,017), e o índice de massa corporal, com a DMO em colo femural (r = 0,563, p = 0,006) e fêmur total (r = 0,529, p = 0,011). Conclusões: Em nossa amostra de mulheres jovens com prolactinoma, 20,83 por cento têm densidade óssea abaixo do esperado para a idade. O maior acometimento de regiões ricas em osso trabecular, como as vértebras, sugere a participação do hipogonadismo na gênese da doença óssea. Independentemente dos valores séricos de prolactina, o retorno dos ciclos menstruais parece ser o melhor índice de bom controle dessas pacientes.


Tumoral hyperprolactinemia and consequent hypogonadism have been associated with osteoporosis. Bone mineral density (BMD) was measured by dual-energy RX absorptiometry in 24 patients with prolactinoma (15 macro and 9 micro adenomas; age range = 18 to 49 years). Student unpaired t or Mann-Whitney tests were used to compare groups, and Spearman test studied correlations. Lumbar spine (LS) was the most affected, as LS Z-score was < -2 SD in 20.83 percent of the patients. No difference was found in densitometric parameters for the comparison between macro and microprolactinoma, or those with normal prolactin versus hyperprolactinemia. LS BMD and LS Z-score were higher in the patients with > 8 menstrual cycles in the preceding year then in those with oligoamenorrhea (p = 0.030). The number of cycles was correlated to LS BMD (r = 0.515, p = 0.017) and body mass index to femoral neck BMD (r = 0.563, p = 0.006) and total femur BMD (r = 0.529, p = 0.011). CONCLUSIONS: Decreased bone mineral density was detected in 20.83 percent of our young patients with prolactinoma. The great involvement of trabecular bone skeletal regions, such as vertebrae, suggests the participation of hypogonadism in the pathogenesis of bone disease. Irrespective of prolactin levels, return to normal menses seems the best index of good control.


Subject(s)
Adolescent , Adult , Female , Humans , Middle Aged , Bone Density/physiology , Hyperprolactinemia/physiopathology , Osteoporosis/physiopathology , Pituitary Neoplasms/physiopathology , Premenopause/physiology , Prolactinoma/physiopathology , Confidence Intervals , Cross-Sectional Studies , Densitometry , Hyperprolactinemia/complications , Menstrual Cycle , Menstruation , Osteoporosis/complications , Pituitary Neoplasms/complications , Prolactinoma/complications , Statistics, Nonparametric
6.
Arq. bras. endocrinol. metab ; 51(8): 1362-1372, nov. 2007. ilus, tab
Article in English | LILACS | ID: lil-471753

ABSTRACT

We review the clinical and biochemical criteria used for evaluation of the transsphenoidal pituitary surgery results in the treatment of Cushing's disease (CD). Firstly, we discuss the pathophysiology of the hypothalamic-pituitary-adrenal axis in normal subjects and patients with CD. Considering the series published in the last 25 years, we observed a significant variation in the remission or cure criteria, including the choice of biochemical tests, timing, threshold values to define remission, and the interference of glucocorticoid replacement or previous treatment. In this context we emphasize serum cortisol levels obtained early (from hours to 12 days) in the postoperative period without any glucocorticoid replacement or treatment. Our experience demonstrates that: (i) early cortisol < 5 to 7 µg/dl, (ii) a period of glucocorticoid dependence > 6 mo, (iii) absence of response of cortisol/ACTH to CRH or DDAVP, (iv) return of dexamethasone suppression, and circadian rhythm of cortisol are appropriate indices of remission of CD. In patients with undetectable cortisol levels early after surgery, recurrence seems to be low. Finally, although certain biochemical patterns are more suggestive of remission or surgical failure, none has been proven to be completely accurate, with recurrence observed in approximately 10 to 15 percent of the patients in long-term follow-up. We recommended that patients with CD should have long-term monitoring of the CRH-ACTH-cortisol axis and associated co-morbidities, especially hypopituitarism, diabetes mellitus, hypertension, cardiovascular disturbances, and osteoporosis.


Neste artigo, são revisados os principais critérios clínicos e hormonais utilizados para avaliação do tratamento cirúrgico da Doença de Cushing (DC). Inicialmente são comentados aspectos fisiopatológicos que orientam a avaliação hormonal e os principais fatores clínicos, laboratoriais, cirúrgicos e histológicos associados com melhores resultados, observados nas principais séries da literatura e em pacientes acompanhados prospectivamente pelos autores. Foram revisados, também, critérios adotados nas principais séries da literatura, nos últimos 25 anos, chamando-se atenção para as dosagens hormonais, o momento em que foram realizadas, a possibilidade de interferência de tratamentos prévios e da reposição glicocorticóide. À seguir, essas dosagens são discutidas salientando-se a importância do cortisol obtido seqüencialmente no pós-operatório e sem a interferência de reposição glicocorticóide. A experiência prospectiva dos autores, recentemente referendada na literatura, demonstra que valores de cortisol < 5 a 7 µg/dl associados com um período de dependência aos glicocorticóides > 6 meses, ausência de resposta do ACTH/cortisol ao DDAVP e/ou CRH, retorno da supressão à dexametasona e do ritmo circadiano, estão associados com remissão da DC. Em pacientes com cortisol indetectável após cirurgia transesfenoidal, a chance de recidiva parece ser menor do que naqueles em que se observa cortisol detectável. Finalmente, chamamos a atenção para que, mesmo adotando critérios rígidos de avaliação, a recidiva da DC pode ocorrer a longo prazo em até 15 por cento dos casos, recomendando-se, portanto, que esses pacientes sejam acompanhados por tempo indeterminado, com monitorização cuidadosa do eixo CRH-ACTH-cortisol e de suas co-morbidades, especialmente hipopituitarismo, diabete melito, hipertensão arterial, alterações cardiovasculares e osteoporose.


Subject(s)
Humans , ACTH-Secreting Pituitary Adenoma , Adenoma , Pituitary ACTH Hypersecretion , Pituitary Neoplasms , ACTH-Secreting Pituitary Adenoma/physiopathology , ACTH-Secreting Pituitary Adenoma/surgery , Adenoma/physiopathology , Adenoma/surgery , Adrenocorticotropic Hormone/blood , Corticotropin-Releasing Hormone/blood , Hypophysectomy , Hydrocortisone/blood , Hydrocortisone/urine , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal Function Tests , Pituitary ACTH Hypersecretion/physiopathology , Pituitary ACTH Hypersecretion/surgery , Pituitary Neoplasms/physiopathology , Pituitary Neoplasms/surgery , Pituitary-Adrenal System/physiopathology , Recurrence , Treatment Outcome
7.
Arq. neuropsiquiatr ; 64(4): 971-975, dez. 2006. ilus, tab
Article in English, Portuguese | LILACS | ID: lil-439753

ABSTRACT

OBJECTIVE: To determine if there was a relationship between intrassellar pressure (ISP) and pituitary tumor volume. METHOD: Between August 2002 and May 2004, 60 patients aged between 13 and 75 years old (39 males), having a pituitary adenoma were submitted to an endoscope transseptal approach. During the surgery and before tumor resection, 2 mm of the sellaÆs floor were removed and a 1.5 mm dural opening made to place a transducer into the pituitary adenoma. The transducer was connected to a pressure monitor. RESULTS: The intrasellar pressure, ranged from 2-51 mmHg and was measured based on the classification of Hardy-Vezina. The most elevated was in the type II macro adenomas with 32.6 mmHg, sharply superior to the value of a normal intracranial pressure. CONCLUSION: These values showed that the macroadenomas confined to the sella, without destruction of the floor and integrity of the diaphragm, type II of Hardy-Vezina, presented a value of ISP much higher than intra-extrasellar macroadenomaÆs.


OBJETIVO: Determinar se existia uma relação entre a pressão intraselar (ISP) e o volume de tumor de hipófise. MÉTODO: Entre agosto de 2002 e maio de 2004, 60 pacientes com idades variando entre 13 e 75 anos (39 homens), portadores de adenoma hipofisários foram operados por via transesfenoidal. Durante o ato cirúrgico e antes da resseção do tumor, uma osteotomia de 2 mm foi realizada no assoalho selar e uma abertura de 1,5 mm na duramater para a introdução de um transdutor dentro do tumor. O transdutor foi conectado a um monitor de pressão e esta foi medida por 2 minutos. RESULTADOS: A pressão intra-selar variou entre 2-51 mmHg e a correlação entre tamanho do tumor e ISP foi baseada na classificação de Hardy-Vezina. A média da ISP mais elevada foi encontrada nos macroadenomas tipo II com 32,6 mmHg, nitidamente superior a pressão intra selar normal. CONCLUSÃO: Estes valores mostram que os macroadenomas confinados a sela sem destruição do assoalho selar e com integridade do diafragma, classificados como tipo II de Hardy-Vezina, apresentam uma ISP muito superior aos outros adenomas.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Adenoma/pathology , Intracranial Pressure , Pituitary Neoplasms/pathology , Sella Turcica/physiopathology , Adenoma/physiopathology , Adenoma/surgery , Preoperative Care , Pituitary Neoplasms/physiopathology , Pituitary Neoplasms/surgery , Transducers, Pressure
8.
Radiol. bras ; 34(1): 17-20, jan.-fev. 2001. ilus
Article in Portuguese | LILACS | ID: lil-283848

ABSTRACT

Procedemos a uma revisão de 95 casos de microadenomas hipofisários, evidenciados por ressonância magnética, nas instituições: Hospital Santa Cruz/Beneficência Portuguesa de Niterói e Clínica X-Labs/Rio de Janeiro. O objetivo foi verificar o tipo principal, incidência, proximidade à haste hipofisária, correlacionando-os com dados clínico-laboratoriais. Os equipamentos utilizados foram de 0,5 Tesla (Gyroscan T5 III da Philips e Vectra da GE) e 1,0 Tesla (Signa da GE), sendo realizadas seqüências rápidas, antes e após administração venosa do meio de contraste paramagnético (gadolínio). Predominaram pacientes do sexo feminino, com prolactinomas, sendo as queixas mais freqüentes: galactorréia, amenorréia e hiperprolactinemia. Em contraste à literatura corrente, observamos que mais freqüentemente a haste hipofisária encontrava-se centrada. Na detecção dos microadenomas é fundamental a injeção venosa do gadolínio o mais próximo possível da aquisição das imagens, sendo recomendável utilizar metade da dose do meio de contraste.


Subject(s)
Humans , Male , Female , Pituitary Neoplasms/physiopathology , Prolactinoma/diagnosis , Magnetic Resonance Spectroscopy
9.
Neurol India ; 1999 Jun; 47(2): 148-51
Article in English | IMSEAR | ID: sea-120270

ABSTRACT

Suprasellar arachnoid cysts (SSAC) are uncommon intracranial lesions. Two patients of SSAC presenting with precocious puberty are described. In both the cases partial excision of the cyst wall, through a pterional craniotomy, establishing communication with the basal subarachnoid spaces was carried out. The endocrinological symptoms regressed after surgery. The clinical presentations of SSAC and the treatment options available are reviewed.


Subject(s)
Child , Craniopharyngioma/physiopathology , Humans , Male , Pituitary Neoplasms/physiopathology , Puberty, Precocious/physiopathology
10.
Article in English | IMSEAR | ID: sea-85389

ABSTRACT

Timed cortisol responses to insulin-hypoglycemia (IH) and arginine-vasopressin (AVP) were compared in 16 patients with pituitary tumors and six healthy controls. Serum cortisol was estimated by a specific and sensitive radioimmunoassay as per the WHO protocol. The basal cortisol (AM) was normal (> 290 nmol/l) in 9 patients and low in seven. With IH peak cortisol response was normal (> 550 nmol/l) in 10 patients, 8 of whom had normal and 2 had low basal (AM) cortisol. In contrast AVP evoked normal cortisol responses in only 5 of these patients, all of whom had normal basal (AM) cortisol and none had low basal (AM) cortisol. The data indicate lower sensitivity for AVP stimulation test (50%) and favour IH as the standard cortisol stimulation test in patients with pituitary tumors awaiting surgery.


Subject(s)
Adolescent , Adult , Arginine Vasopressin/diagnosis , Female , Humans , Hydrocortisone/blood , Hypoglycemia/chemically induced , Hypothalamo-Hypophyseal System/physiology , Insulin/diagnosis , Male , Pituitary Neoplasms/physiopathology , Pituitary-Adrenal Function Tests , Pituitary-Adrenal System/physiology
11.
Arq. neuropsiquiatr ; 55(4): 818-25, dez. 1997. ilus, tab
Article in Portuguese | LILACS | ID: lil-209382

ABSTRACT

Os autores analisam a literatura sobre apoplexia hipofisária intradenomatosa, enfocando a fisiopatologia, o diagnóstico e a conduta terapêutica. Estudam 5 casos, de uma série de 86 pacientes com tumores hipofisários que desenvolveram esta síndrome e que foram diagnosticados e acompanhados pelos serviços de Neurocirurgia e Endocrinologia do Hospital Universitário Clementino Fraga Filho da Universidade Federal do Rio de Janeiro. Todos os casos, a partir da suspeita clínica, tiveram o diagnóstico confirmado por estudo de tomografia computadorizada de crânio e/ou ressonância magnética de crânio. O tratamento de escolha foi cirúrgico. As conclusöes apontam para as dificuldades diagnósticas desta situaçao clínica e da urgência na instituiçäo da terapia.


Subject(s)
Male , Humans , Female , Middle Aged , Adult , Adenoma/diagnosis , Pituitary Apoplexy/diagnosis , Pituitary Neoplasms/diagnosis , Adenoma/physiopathology , Magnetic Resonance Imaging , Pituitary Apoplexy/surgery , Pituitary Gland/pathology , Pituitary Neoplasms/physiopathology
13.
J Indian Med Assoc ; 1994 Jul; 92(7): 225-8
Article in English | IMSEAR | ID: sea-98852

ABSTRACT

A study of median nerve sensory conduction at the wrist was performed in 34 patients with pituitary adenomas prior to and following surgery. In 31 patients this was done bilaterally. They included 11 patients with acromegalic features, 3 of whom had features of carpal tunnel syndrome. Six out of 11 (55%) acromegalics had abnormal latencies and conduction velocities pre-operatively. Among the remaining patients only 3 had conduction delay pre-operatively. Postoperative improvement in conduction velocity and latency was recorded in 24 patients although significant improvement was observed in only 13 patients. All 3 patients with carpal tunnel syndrome had significant improvement in conduction velocities and latencies following the surgery. There was no definite relationship between conduction velocity and the pre-operative hormonal profile.


Subject(s)
Acromegaly/physiopathology , Adenoma/physiopathology , Adolescent , Adult , Carpal Tunnel Syndrome/physiopathology , Female , Follow-Up Studies , Humans , Male , Median Nerve/physiopathology , Middle Aged , Pituitary Neoplasms/physiopathology , Postoperative Complications/physiopathology , Reaction Time/physiology , Synaptic Transmission/physiology
14.
Braz. j. med. biol. res ; 26(9): 933-41, Sept. 1993. tab, graf
Article in English | LILACS | ID: lil-148765

ABSTRACT

1. The association between hypogonadism and osteoporosis has been reported. We conducted a study to establish the prevalence and magnitude of osteopenia in patients with prolactinoma and the relationship of bone loss with the duration of hypogonadism. 2. We measured the bone mineral density (BMD) of spine and femur (a site that has not been analyzed earlier) in 35 patients with prolactinoma using a dual-energy X-ray absorptiometer. The patients were classified as normal BMD and low BMD (osteopenics). 3. Seventeen patients (48 per cent ) showed osteopenia. The mean bone loss in the different regions was: spine, 13 per cent ; femoral neck, 15 per cent ; trochanter, 11 per cent ; Ward's, 22 per cent . This difference was only significant when the spine and Ward's region were compared. The duration of hypogonadism was significantly greater in the low-BMD group (11.3 vs 4.9 years) when compared to the normal BMD group. There was a positive relationship between the duration of hypogonadism and magnitude of bone loss in both spine and femur (P = 0.04; r = 0.6). 4. A high prevalence of osteopenia in both spine and femur was found in patients with prolactinoma, and was highly associated with the duration of hypogonadism. Early treatment of this condition seems important to prevent bone loss


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Bone Diseases, Metabolic/complications , Pituitary Neoplasms/complications , Prolactinoma/complications , Absorptiometry, Photon , Age Factors , Bone Density , Bone Diseases, Metabolic/epidemiology , Femur , Hyperprolactinemia/complications , Hyperprolactinemia/physiopathology , Hypogonadism/complications , Osteoporosis/epidemiology , Osteoporosis/etiology , Pituitary Neoplasms/physiopathology , Prevalence , Prolactinoma , Spine
17.
Acta méd. colomb ; 6(3): 257-70, sept. 1981. ilus, tab
Article in Spanish | LILACS | ID: lil-70385

ABSTRACT

Con el objeto de verificar el concepto de que la hormona del crecimiento esta contenida en poblaciones de celulas acidofilas, se realizo la deteccion inmunocitoquimica de la hormona en cortes histologicos de adenohipofisis humana fijados en formalina. Se utilizo la reaccion inmunocitoquimica de peroxidasa antiperoxidasa (PAP). se encontro que las celulas detectadas inmunocitoquimicamente como productoras de la hormona del crecimiento (GH), corresponden a las celulas acidofilas naranjas en la reaccion de tincion naranja G. delineadas clara y especificamente por el metodo PAP, estas celulas fueron observadas formando filas a lo largo de sinusoides. Se presenta la ultraestructura de estas celulas y se compara con las observaciones hechas por otros autores. Se describe ademas la utilidad del metodo para detectar la hormona de crecimiento en adenomas de la pituitaria y sus metastasis. Finalmente se discute el papel de la hormona en el crecimiento y se analizan las perspectivas de investigacion y la utilizacion practica de ella en el tratamiento de algunas entidades clinicas y en el incremento del crecimiento


Subject(s)
Humans , Growth Hormone/biosynthesis , Growth Hormone/physiology , Growth Hormone/therapeutic use , Histocytochemistry , Immunoenzyme Techniques , In Vitro Techniques , Pituitary Gland, Anterior/cytology , Pituitary Gland, Anterior/physiology , Pituitary Gland, Anterior/ultrastructure , Pituitary Hormones, Anterior/biosynthesis , Pituitary Hormones, Anterior/physiology , Pituitary Neoplasms/physiopathology , Colombia
SELECTION OF CITATIONS
SEARCH DETAIL